Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Read more about Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells. Patent Cooperation TreatyPCT/US2002/030316Filed on 2002-09-25
AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Read more about AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE US Patent 6,812,246Filed on 2003-06-12
Filtration of Red Blood Cells Read more about Filtration of Red Blood Cells US Application 10/289,686Filed on 2002-11-06
CYCLIN DEPENDENT KINASE (CDK4) INHIBITORS AND THEIR USE FOR TREATING CANCER Read more about CYCLIN DEPENDENT KINASE (CDK4) INHIBITORS AND THEIR USE FOR TREATING CANCER US Application 10/308,343Filed on 2002-12-02
A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Read more about A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Japan2002-510097Filed on 2001-06-15
A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Read more about A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Australia2001268452Filed on 2001-06-15
A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Read more about A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Canada2412050Filed on 2001-06-15
A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Read more about A Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses European Patent01946395.9Filed on 2001-06-15
Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses Read more about Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses US Application 10/297,168Filed on 2003-07-16
PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Read more about PEGYLATION OF LINKERS IMPROVES ANTITUMOR ACTIVITY AND REDUCES TOXICITY OF IMMUNOCONJUGATES Australia2001269762Filed on 2001-06-08